Delivery Order SPE2DB25D7068-SPE2DB25FTXVM
- Not listed
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $14,404.40 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a $14,404.40 delivery order (Contract No. 4569367439) to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,100.66 to AmerisourceBergen Drug Corp for Act-O-Vials on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. Performance will occur at the contractor's Corporate Office location...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,307.41 to AmerisourceBergen Drug Corp on July 14, 2025, with completion expected by July 15, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $109,461.87 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The order...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $10,873.56 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,229.04 to AmerisourceBergen Drug Corp on September 7, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from the vendor's Corporate Office location in Conshohocken,...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXVMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 3, 2025, with completion expected by September 4, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Through its comprehensive IDC with DLA, the company supplies an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for ACT-O-VIALS reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through flexible contract mechanisms designed to meet global pharmaceutical supply requirements for military operations and personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/3/25 |